AMANDA SCHMIEDL: Open Payments
NPI 1639672488 · CLEVELAND, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$384 in 4 payments from 4 companies in 2025. Trend: 2023 $65 · 2024 $233 · 2025 $384
Food & beverage: $384
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 1 | $134 |
| Astellas Pharma US Inc | 1 | $123 |
| GlaxoSmithKline, LLC. | 1 | $98 |
| Iovance Biotherapeutics, Inc. | 1 | $28 |
Products named: RYBREVANT, Cresemba, JEMPERLI, Amtagvi.
Industry payments across OH — which companies pay providers there.
